全文获取类型
收费全文 | 5056篇 |
免费 | 294篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 208篇 |
妇产科学 | 117篇 |
基础医学 | 532篇 |
口腔科学 | 134篇 |
临床医学 | 409篇 |
内科学 | 1687篇 |
皮肤病学 | 94篇 |
神经病学 | 393篇 |
特种医学 | 211篇 |
外科学 | 536篇 |
综合类 | 38篇 |
一般理论 | 1篇 |
预防医学 | 198篇 |
眼科学 | 28篇 |
药学 | 351篇 |
1篇 | |
中国医学 | 7篇 |
肿瘤学 | 403篇 |
出版年
2023年 | 28篇 |
2022年 | 43篇 |
2021年 | 106篇 |
2020年 | 45篇 |
2019年 | 97篇 |
2018年 | 123篇 |
2017年 | 88篇 |
2016年 | 101篇 |
2015年 | 85篇 |
2014年 | 144篇 |
2013年 | 203篇 |
2012年 | 236篇 |
2011年 | 248篇 |
2010年 | 156篇 |
2009年 | 152篇 |
2008年 | 205篇 |
2007年 | 260篇 |
2006年 | 248篇 |
2005年 | 243篇 |
2004年 | 204篇 |
2003年 | 189篇 |
2002年 | 193篇 |
2001年 | 167篇 |
2000年 | 170篇 |
1999年 | 157篇 |
1998年 | 81篇 |
1997年 | 89篇 |
1996年 | 78篇 |
1995年 | 61篇 |
1994年 | 64篇 |
1993年 | 48篇 |
1992年 | 108篇 |
1991年 | 69篇 |
1990年 | 87篇 |
1989年 | 83篇 |
1988年 | 76篇 |
1987年 | 73篇 |
1986年 | 58篇 |
1985年 | 58篇 |
1984年 | 57篇 |
1983年 | 66篇 |
1982年 | 32篇 |
1981年 | 24篇 |
1980年 | 18篇 |
1979年 | 26篇 |
1978年 | 22篇 |
1976年 | 20篇 |
1975年 | 25篇 |
1974年 | 26篇 |
1970年 | 20篇 |
排序方式: 共有5372条查询结果,搜索用时 15 毫秒
91.
Maria A. Rocca Roberta Messina Bruno Colombo Andrea Falini Giancarlo Comi Massimo Filippi 《Journal of neurology》2014,261(2):350-357
Morphometric MRI studies in adult patients with migraine have consistently demonstrated atrophy of several gray matter (GM) regions involved in pain processing. We explored the regional distribution of GM and white matter (WM) abnormalities in pediatric patients with episodic migraine and their correlations with disease clinical manifestations. Using a 3.0 T scanner, brain T2-weighted and 3D T1-weighted scans were acquired from 12 pediatric migraine patients and 15 age-matched healthy controls. GM and WM volumetric abnormalities were estimated using voxel-based morphometry (p < 0.05, family-wise error corrected). Compared to controls, pediatric migraine patients experienced a significant GM atrophy of several regions of the frontal and temporal lobes which are part of the pain-processing network. They also had an increased volume of the right putamen. The left fusiform gyrus had an increased volume in patients with aura compared to patients without aura and controls, whereas it was significantly atrophied in patients without aura when compared to the other two groups. No abnormalities of WM volume were detected. In migraine patients, regional GM atrophy was not correlated with disease duration and attack frequency, whereas a negative correlation was found between increased volume of the putamen and disease duration (r = ?0.95, p < 0.05). These results show that GM morphometric abnormalities do occur in pediatric patients with migraine. The presence of such abnormalities early in the disease course, and the absence of correlation with patient clinical characteristics suggest that they may represent a phenotypic biomarker of this condition. 相似文献
92.
93.
94.
Yuli R Tak Rinka MP Van Zundert Rowella CWM Kuijpers Boukje S Van Vlokhoven Hettie FW Rensink Rutger CME Engels 《BMC public health》2012,12(1):21
Background
The incidence of depressive symptoms increases during adolescence, from 10.0% to 24.5% at age 11 to 15, respectively. Experiencing elevated levels of depressive symptoms increases the risk of a depressive disorder in adulthood. A universal school-based depression prevention program Op Volle Kracht (OVK) was developed, based on the Penn Resiliency Program, aimed at preventing the increase of depressive symptoms during adolescence and enhancing positive development. In this study the effectiveness of OVK will be tested and possible mediators of program effects will be focus of study as well. 相似文献95.
Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation 总被引:7,自引:0,他引:7
Alessandrino EP Bernasconi P Caldera D Colombo A Malcovati L Martinelli G Bonfichi M Pagnucco G Salvaneschi L Bernasconi C 《Bone marrow transplantation》1999,23(6):607-612
Ten patients with acute leukemia (AL) in early relapse after allo-BMT were treated with a modified MEC (mitoxantrone, etoposide and Ara-C) regimen followed by donor PBPC collected after mobilization with G-CSF. Seven patients achieved CR or had normal hemopoietic reconstitution: two had an early relapse at days +53 and +48, two patients died from acute GVHD at days +31 and +96, one died of interstitial pneumonia at day +55, and two patients experienced long-term survival. One patient with refractory disease and nodal involvement who did not respond to the first BMT had overt expansion of the leukemia at day +36; one patient with Ph+ ALL and one with ANLL evolving from MDS, both with skin involvement, had blast cells in peripheral blood at day +27 and +26, respectively. Transient cytopenia occurred in all patients; a normal granulocyte and platelet count was achieved within 3 weeks in all patients but one; acute GVHD occurred in six patients, and four had chronic GVHD. This approach is feasible in patients in early relapse after allo-BMT. It assists prompt re-establishment of normal donor hematopoiesis avoiding the prolonged cytopenia observed after donor lymphocyte infusion in AL patients relapsed after allo-BMT. 相似文献
96.
97.
Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study 总被引:3,自引:0,他引:3
We examined assembly and expression of the factor X activating complex on human and rabbit alveolar macrophages. Kinetic parameters of the factor X activating reaction were determined by functional titrations of factors VII and X with macrophage tissue factor (TF) added. We found rapid activation of factor X to Xa on alveolar macrophage surfaces. Detection of rapid factor Xa formation on macrophages required addition of exogenous factors VII and X. At plasma concentrations of the purified factors, factor Xa was formed on freshly isolated macrophages at approximately 5.4 pmol/min/10(6) cells. After macrophage maturation in culture for 20 hours with LPS (endotoxin) added, the factor X activation rate was increased two- to sixfold. The km' (apparent km) of TF-factor VII enzymatic complexes assembled on alveolar macrophages for factor X were (258 +/- 55 and 475 +/- 264 nmol/L for human and rabbit cells, respectively). The km' did not change during macrophage maturation in culture, but V'max (apparent Vmax) was consistently increased. The K1/2 of human factor VII (concentrations giving half maximal rates of factor X activation) for the interaction with human and rabbit alveolar macrophage TF were 0.191 +/- 0.096 and 1.7 +/- 0.7 etamol/L, respectively. The K1/2 were not significantly changed after maturation, whereas rates of Xa formation at saturation with factor VII were increased. The fast rates of factor X activation observed at physiologic concentrations of plasma-derived factors VII and X indicate that TF on alveolar macrophages is likely to provide sites for binding of factor VII and activation of factor X in vivo during clotting reactions associated with alveolar edema and inflammation. 相似文献
98.
99.
Laura Castelnovo Antonio Tamburello Alfredo Lurati Eleonora Zaccara Maria Grazia Marrazza Micol Olivetti Nicola Mumoli Daniela Mastroiacovo Daniele Colombo Elisabetta Ricchiuti Paolo Vigano Faggioli Paola Antonino Mazzone 《Medicine》2021,100(1)
COVID-19 is causing a high influx of patients suffering from serious respiratory complications leading the necessity to find effective therapies. These patients seem to present with cytokine perturbation and high levels of IL6. Tocilizumab and sarilumab could be effective in this condition.We retrospectively collected data about 112 consecutive hospitalized in a single center.Fifty (IL6 group) treated with tocilizumab (8 mg/kg intravenously [IV], 2 infusions 12 hours apart) or sarilumab 400 mg IV once and 62 treated with the standard of care but not anti-cytokine drugs (CONTROL group).To determine whether anti-IL6 drugs are effective in improving prognosis and reducing hospitalization times and mortality in COVID-19 pneumonia.To date 84% (42/50) of IL6 group patients have already been discharged and only 2/50 are still recovered and intubated in intensive care. Six/fifty patients (12%) died: 5/6 due to severe respiratory failure within a framework of severe acute respiratory distress syndrome (ARDS), 1 suffered an acute myocardial infarction, and 1 died of massive pulmonary thromboembolism. There were no adverse treatment events or infectious complications. Compared to the CONTROL group they showed a lower mortality rate (12% versus 43%), for the same number of complications and days of hospitalization.Anti-IL6 drugs seem to be effective in the treatment of medium to severe forms of COVID-19 pneumonia reducing the risk of mortality due to multi-organ failure, acting at the systemic level and reducing inflammation levels and therefore microvascular complications. However, it is essential to identify the best time for treatment, which, if delayed, is rendered useless as well as counterproductive. Further studies and ongoing clinical trials will help us to better define patients eligible as candidates for more aggressive intervention. 相似文献
100.
Dejan Orlic Bernhard Reimers Goran Stankovic Nicola Corvaja Alaide Chieffo Flavio Airoldi Vassilis Spanos Luca Favero Carlo Di Mario Antonio Colombo 《Catheterization and cardiovascular interventions》2003,60(2):159-166
The purpose of this study was to evaluate the safety and efficacy of the new Fox Hollow atherectomy device (FHT) designed for more efficient and easier plaque removal. The FHT has short rigid section and low-profile cutter mounted on a monorail catheter. The FHT catheter was utilized in 77 patients with 98 lesions. Mean reference vessel diameter was 2.75 +/- 0.51 mm. Successful atherectomy with tissue retrieval was performed in 94 lesions (96%). Following atherectomy, mean diameter stenosis was reduced from 71.1% to 31.9% and further to 10.4% following adjunctive treatment. Angiographic complications were one coronary perforation and one adventitial staining, both successfully treated with prolong balloon inflation and stent implantation. Nine patients (11.7%) had in-hospital non-Q-wave myocardial infarction (MI). One patient died (1.3%) for noncardiac reasons and one had MI (1.3%) at 6-month follow-up. Target lesion revascularization was required in 13 (13.8%) lesions and target vessel revascularization in 15 (20.3%) patients. There was target vessel failure in 17 (23.0%) patients. Plaque debulking with the FHT catheter can be performed safely and effectively in relatively small vessels and complex lesions located in mid-distal artery segments with 6-month clinical outcome similar to prior atherectomy devices. 相似文献